Green Light Committee application instructions

Overview

Management of drug-resistant tuberculosis (DR-TB) under programmatic conditions is a complex intervention in public health, not yet fully established in many countries. The treatment that does not meet international standards, however, risks amplifying and spreading multidrug-resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB) further. The global response to MDR-TB and XDR-TB, embedded in the Global Plan to Stop TB 2006-20151, has the target of achieving universal access to diagnosis and treatment of MDR-TB by 2015.

The GLC a subgroup of the Stop TB Partnership’s Working Group on MDR-TB and serves both WHO and the Stop TB Partnership as an advisory body.